Raloxifene offers a unique profile among anti-estrogens with testosterone-boosting potential. Studies in older men show daily administration can lead to a moderate increase in serum testosterone levels, benefiting those undergoing post-cycle therapy. It suppresses IGF-1 levels by antagonizing estrogen, which may have implications in conditions like acromegaly. However, its use should be carefully considered as it may reduce the anabolic efficacy of steroid therapy by dampening estrogen’s beneficial roles in tissue repair and growth.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Raloxifene 20 by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.